Target intelligence / Profile preview

TNF alpha induced protein 2 (TNFAIP2)

Target
TNFAIP2
Molecular classification
Other (regulatory/effector protein, not a classical receptor, enzyme, transporter, or transcription factor), SNARE-binding protein
01

Overview

TNF alpha induced protein 2 (TNFAIP2) is a protein-coding gene whose expression is upregulated in response to tumor necrosis factor alpha (TNFα) and other cytokines. It acts as a multi-functional mediator with established roles in inflammation, angiogenesis, regulation of cell migration and proliferation, and the formation of tunneling nanotubes (TNTs) that connect cells for intercellular communication. TNFAIP2 is induced via the NF-κB pathway in immune and endothelial cells, and interacts with the cytoskeleton and exocyst complex during cell migration. Aberrant expression has been implicated in a variety of cancers, serving as both a diagnostic and prognostic biomarker in specific tumor types. TNFAIP2 is considered a candidate therapeutic target due to its functions in cancer biology and immune regulation, although approved drugs specifically targeting this protein do not yet exist.

Other names
Tumor necrosis factor, alpha-induced protein 2Exocyst complex component 3-like 3B94M-Sec
02

Mechanism of action

Not applicable for direct drugs (since none are clinically used), but hypothetical mechanisms in development focus on inhibition or gene-editing to alter cancer cell proliferation and migration. Potential knockdown or genetic editing used to block angiogenesis, migration, and tunneling nanotube formation in cancer.

03

Biological functions

Inflammation mediatorAngiogenesis mediatorCell proliferation regulatorCell migration facilitatorMembrane nanotube (tunneling nanotube, TNT) formationImmune response
04

Disease associations

Cancer (diagnostic and prognostic relevance, particularly in Hodgkin lymphoma, kidney cancer, glioma, thymoma, bladder carcinoma, sarcoma, melanoma, and more)InflammationInfection (antiviral activity, role in infectious disease susceptibility)
05

Safety considerations

Potential safety concerns are unknown in humans due to the absence of clinically-approved targeting agents.Given its role in immune responses and cell migration, inhibition may, in theory, impact immune function, inflammation, and tissue repair negatively.
06

Interacting drugs

There are currently no approved drugs known to directly target TNF alpha induced protein 2.

2 more in the full profile.

07

Biomarkers

TNFAIP2 expression as a marker in diagnostic panelsTNFAIP2 expression as a prognostic biomarker in Hodgkin lymphomaTNFAIP2 expression as a prognostic biomarker in Acute myeloid leukemia subgroupsTNFAIP2 expression as a prognostic biomarker in Classical Hodgkin lymphoma versus other lymphomasTNFAIP2 expression as a prognostic biomarker in some solid tumors (e.g., bladder carcinoma, kidney cancer, glioma, melanoma)

Beyond the preview

Go deeper on TNF alpha induced protein 2 (TNFAIP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TNF alpha induced protein 2 (TNFAIP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call